{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T09:40:30Z","timestamp":1771494030992,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,8,7]],"date-time":"2010-08-07T00:00:00Z","timestamp":1281139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00198-010-1368-1","type":"journal-article","created":{"date-parts":[[2010,8,6]],"date-time":"2010-08-06T11:52:57Z","timestamp":1281095577000},"page":"1555-1571","source":"Crossref","is-referenced-by-count":22,"title":["Bisphosphonate use and risk of post-operative fracture among patients undergoing a total knee replacement for knee osteoarthritis: a propensity score analysis"],"prefix":"10.1007","volume":"22","author":[{"given":"D.","family":"Prieto-Alhambra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. K.","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Judge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. K.","family":"Arden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,7]]},"reference":[{"key":"1368_CR1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF01623184","volume":"2","author":"C Cooper","year":"1992","unstructured":"Cooper C, Campion G, Melton LJ 3rd (1992) Hip fractures in the elderly: a world-wide projection. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2:285\u2013289","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"1368_CR2","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/art.1780300811","volume":"30","author":"DT Felson","year":"1987","unstructured":"Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF (1987) The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum 30:914\u2013918","journal-title":"Arthritis Rheum"},{"key":"1368_CR3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/rheumatology\/keh045","volume":"43","author":"KM Jordan","year":"2004","unstructured":"Jordan KM, Sawyer S, Coakley P, Smith HE, Cooper C, Arden NK (2004) The use of conventional and complementary treatments for knee osteoarthritis in the community. Rheumatology (Oxford, England) 43:381\u2013384","journal-title":"Rheumatology (Oxford, England)"},{"key":"1368_CR4","unstructured":"National Joint R (2009) National Joint Registry for England and Wales. 6th Annual Report"},{"key":"1368_CR5","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0883-5403(94)90093-0","volume":"9","author":"A Laupacis","year":"1994","unstructured":"Laupacis A, Bourne R, Rorabeck C, Feeny D, Wong C, Tugwell P, Leslie K, Bullas R (1994) Costs of elective total hip arthroplasty during the first year. Cemented versus noncemented. J Arthroplasty 9:481\u2013487","journal-title":"J Arthroplasty"},{"key":"1368_CR6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/ard.31.4.259","volume":"31","author":"MV Foss","year":"1972","unstructured":"Foss MV, Byers PD (1972) Bone density, osteoarthrosis of the hip, and fracture of the upper end of the femur. Ann Rheum Dis 31:259\u2013264","journal-title":"Ann Rheum Dis"},{"key":"1368_CR7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/art.1780380706","volume":"38","author":"MC Nevitt","year":"1995","unstructured":"Nevitt MC, Lane NE, Scott JC, Hochberg MC, Pressman AR, Genant HK, Cummings SR (1995) Radiographic osteoarthritis of the hip and bone mineral density. The Study of Osteoporotic Fractures Research Group. Arthritis Rheum 38:907\u2013916","journal-title":"Arthritis Rheum"},{"key":"1368_CR8","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/art.1780361205","volume":"36","author":"MT Hannan","year":"1993","unstructured":"Hannan MT, Anderson JJ, Zhang Y, Levy D, Felson DT (1993) Bone mineral density and knee osteoarthritis in elderly men and women. The Framingham Study. Arthritis Rheum 36:1671\u20131680","journal-title":"Arthritis Rheum"},{"key":"1368_CR9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.joca.2008.06.004","volume":"17","author":"M Abdin-Mohamed","year":"2009","unstructured":"Abdin-Mohamed M, Jameson K, Dennison EM, Cooper C, Arden NK, Hertfordshire Cohort Study G (2009) Volumetric bone mineral density of the tibia is not increased in subjects with radiographic knee osteoarthritis. Osteoarthritis and cartilage\/OARS, Osteoarthritis Research Society 17:174\u2013177","journal-title":"Osteoarthritis and cartilage\/OARS, Osteoarthritis Research Society"},{"key":"1368_CR10","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/rheumatology\/35.12.1299","volume":"35","author":"NK Arden","year":"1996","unstructured":"Arden NK, Griffiths GO, Hart DJ, Doyle DV, Spector TD (1996) The association between osteoarthritis and osteoporotic fracture: the Chingford Study. Br J Rheumatol 35:1299\u20131304","journal-title":"Br J Rheumatol"},{"key":"1368_CR11","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/art.11380","volume":"49","author":"AP Bergink","year":"2003","unstructured":"Bergink AP, van der Klift M, Hofman A, Verhaar JA, van Leeuwen JP, Uitterlinden AG, Pols HA (2003) Osteoarthritis of the knee is associated with vertebral and nonvertebral fractures in the elderly: the Rotterdam Study. Arthritis Rheum 49:648\u2013657","journal-title":"Arthritis Rheum"},{"key":"1368_CR12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/art.22088","volume":"55","author":"NK Arden","year":"2006","unstructured":"Arden NK, Crozier S, Smith H, Anderson F, Edwards C, Raphael H, Cooper C (2006) Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis Rheum 55:610\u2013615","journal-title":"Arthritis Rheum"},{"key":"1368_CR13","doi-asserted-by":"crossref","unstructured":"Prieto-Alhambra D, Javaid M, Maskell J, Judge A, Nevitt M, Cooper C, Arden NK (2010) Changes in Hip Fracture Rate before and after total knee replacement due to Osteoarthritis: a population-based cohort study. Ann Rheum Dis (in press)","DOI":"10.1136\/ard.2010.131110"},{"key":"1368_CR14","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jc.85.11.4118","volume":"85","author":"DM Black","year":"2000","unstructured":"Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85:4118\u20134124","journal-title":"J Clin Endocrinol Metab"},{"key":"1368_CR15","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","volume":"282","author":"ST Harris","year":"1999","unstructured":"Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282:1344\u20131352","journal-title":"JAMA"},{"key":"1368_CR16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","volume":"282","author":"B Ettinger","year":"1999","unstructured":"Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637\u2013645","journal-title":"JAMA"},{"issue":"Suppl 1","key":"1368_CR17","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/01.bor.0000229523.89546.32","volume":"18","author":"E Seeman","year":"2006","unstructured":"Seeman E (2006) Strontium ranelate: vertebral and non-vertebral fracture risk reduction. Curr Opin Rheumatol 18(Suppl 1):S17\u2013S20","journal-title":"Curr Opin Rheumatol"},{"key":"1368_CR18","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF03327362","volume":"15","author":"TD Spector","year":"2003","unstructured":"Spector TD (2003) Bisphosphonates: potential therapeutic agents for disease modification in osteoarthritis. Aging Clin Exp Res 15:413\u2013418","journal-title":"Aging Clin Exp Res"},{"key":"1368_CR19","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1002\/art.22160","volume":"54","author":"CO Bingham 3rd","year":"2006","unstructured":"Bingham CO 3rd, Buckland-Wright JC, Garnero P, Cohen SB, Dougados M, Adami S, Clauw DJ, Spector TD, Pelletier JP, Raynauld JP, Strand V, Simon LS, Meyer JM, Cline GA, Beary JF (2006) Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 54:3494\u20133507","journal-title":"Arthritis Rheum"},{"key":"1368_CR20","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(97)04248-7","volume":"350","author":"T Walley","year":"1997","unstructured":"Walley T, Mantgani A (1997) The UK General Practice Research Database. Lancet 350:1097\u20131099","journal-title":"Lancet"},{"key":"1368_CR21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","volume":"19","author":"JA Kanis","year":"2008","unstructured":"Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E (2008) FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int 19:385\u2013397","journal-title":"Osteoporos Int"},{"key":"1368_CR22","unstructured":"Kanis JA, Group WHOS (2007) Assessment of osteoporosis at the primary health care level. WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield 2007 (available on request from the WHO Collaborating Centre or the IOF)"},{"key":"1368_CR23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/1099-1557(200009\/10)9:5<359::AID-PDS507>3.0.CO;2-E","volume":"9","author":"TP Staa Van","year":"2000","unstructured":"Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HG (2000) The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 9:359\u2013366","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1368_CR24","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1185\/030079906X112688","volume":"22","author":"E Brankin","year":"2006","unstructured":"Brankin E, Walker M, Lynch N, Aspray T, Lis Y, Cowell W (2006) The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases. Curr Med Res Opin 22:1249\u20131256","journal-title":"Curr Med Res Opin"},{"key":"1368_CR25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/biomet\/70.1.41","volume":"70","author":"PR Rosenbaum","year":"1983","unstructured":"Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70:15","journal-title":"Biometrika"},{"key":"1368_CR26","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/0003-4819-137-8-200210150-00015","volume":"137","author":"LE Braitman","year":"2002","unstructured":"Braitman LE, Rosenbaum PR (2002) Rare outcomes, common treatments: analytic strategies using propensity scores. Ann Intern Med 137:693\u2013695","journal-title":"Ann Intern Med"},{"key":"1368_CR27","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1136\/bmj.330.7498.1021","volume":"330","author":"SL Normand","year":"2005","unstructured":"Normand SL, Sykora K, Li P, Mamdani M, Rochon PA, Anderson GM (2005) Readers guide to critical appraisal of cohort studies: 3. Analytical strategies to reduce confounding. BMJ 330:1021\u20131023","journal-title":"BMJ"},{"key":"1368_CR28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","volume":"51","author":"PC Austin","year":"2009","unstructured":"Austin PC (2009) Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations. Biom J 51:171\u2013184","journal-title":"Biom J"},{"key":"1368_CR29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1503\/cmaj.1021197","volume":"171","author":"A Barratt","year":"2004","unstructured":"Barratt A, Wyer PC, Hatala R, McGinn T, Dans AL, Keitz S, Moyer V, For GG (2004) Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat. CMAJ 171:353\u2013358","journal-title":"CMAJ"},{"key":"1368_CR30","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","volume":"353","author":"JR Center","year":"1999","unstructured":"Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA (1999) Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet 353:878\u2013882","journal-title":"Lancet"},{"key":"1368_CR31","doi-asserted-by":"crossref","first-page":"R625","DOI":"10.1186\/ar1716","volume":"7","author":"TD Spector","year":"2005","unstructured":"Spector TD, Conaghan PG, Buckland-Wright JC, Garnero P, Cline GA, Beary JF, Valent DJ, Meyer JM (2005) Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther 7:R625\u2013R633","journal-title":"Arthritis Res Ther"},{"key":"1368_CR32","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1002\/art.20627","volume":"50","author":"LD Carbone","year":"2004","unstructured":"Carbone LD, Nevitt MC, Wildy K, Barrow KD, Harris F, Felson D, Peterfy C, Visser M, Harris TB, Wang BW, Kritchevsky SB, Health A, Body Composition S (2004) The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 50:3516\u20133525","journal-title":"Arthritis Rheum"},{"key":"1368_CR33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/rheumatology\/kel213","volume":"46","author":"JC Buckland-Wright","year":"2007","unstructured":"Buckland-Wright JC, Messent EA, Bingham CO 3rd, Ward RJ, Tonkin C (2007) A 2\u00a0yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. Rheumatology (Oxford) 46:257\u2013264","journal-title":"Rheumatology (Oxford)"},{"key":"1368_CR34","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","volume":"85","author":"DM Black","year":"2000","unstructured":"Black DM, Thompson DE, Bauer DC, Ensrud K, Musliner T, Hochberg MC, Nevitt MC, Suryawanshi S, Cummings SR, Fracture Intervention T (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85:4118\u20134124","journal-title":"J Clin Endocrinol Metab"},{"key":"1368_CR35","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","volume":"280","author":"SR Cummings","year":"1998","unstructured":"Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, Palermo L, Prineas R, Rubin SM, Scott JC, Vogt T, Wallace R, Yates AJ, LaCroix AZ (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077\u20132082","journal-title":"JAMA"},{"key":"1368_CR36","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/s00198-008-0795-8","volume":"20","author":"O Sheehy","year":"2009","unstructured":"Sheehy O, Kindundu CM, Barbeau M, LeLorier J (2009) Differences in persistence among different weekly oral bisphosphonate medications. Osteoporos Int 20:1369\u20131376","journal-title":"Osteoporos Int"},{"key":"1368_CR37","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00198-004-1652-z","volume":"15","author":"JJ Caro","year":"2004","unstructured":"Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C (2004) The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 15:1003\u20131008","journal-title":"Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA"},{"key":"1368_CR38","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jclinepi.2007.07.011","volume":"61","author":"PC Austin","year":"2008","unstructured":"Austin PC (2008) The performance of different propensity-score methods for estimating relative risks. J Clin Epidemiol 61:537\u2013545","journal-title":"J Clin Epidemiol"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1368-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-010-1368-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-010-1368-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T11:19:53Z","timestamp":1559387993000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-010-1368-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,7]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["1368"],"URL":"https:\/\/doi.org\/10.1007\/s00198-010-1368-1","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,7]]}}}